AA
VIRX
Addison Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4
| Closed | -$1 | – | 886 |
|
|
2024
Q4 | $1 | Hold |
4
| – | – | ﹤0.01% | 839 |
|
|
2024
Q3 | $1 | Hold |
4
| – | – | ﹤0.01% | 835 |
|
|
2024
Q2 | $3 | Hold |
4
| – | – | ﹤0.01% | 774 |
|
|
2024
Q1 | $5 | Hold |
4
| – | – | ﹤0.01% | 696 |
|
|
2023
Q4 | $3 | Hold |
4
| – | – | ﹤0.01% | 702 |
|
|
2023
Q3 | $5 | Hold |
4
| – | – | ﹤0.01% | 678 |
|
|
2023
Q2 | $6 | Hold |
4
| – | – | ﹤0.01% | 628 |
|
|
2023
Q1 | $7 | Hold |
4
| – | – | ﹤0.01% | 627 |
|
|
2022
Q4 | $6 | Hold |
4
| – | – | ﹤0.01% | 785 |
|
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 785 |
|
|
2022
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 792 |
|
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 802 |
|
|
2021
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 729 |
|
|
2021
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 463 |
|
|
2021
Q2 | $0 | Buy |
+4
| New | – | ﹤0.01% | 410 |
|
|
2020
Q4 | $0 | Buy |
+16
| New | – | ﹤0.01% | 387 |
|